Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-246843
Filing Date
2011-09-13
Accepted
2011-09-13 16:01:35
Documents
6
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d227415d10k.htm 10-K 1027053
2 CONSENT OF ERNST & YOUNG LLP d227415dex231.htm EX-23.1 2156
3 SECTION 302 CEO CERTIFICATION d227415dex311.htm EX-31.1 8093
4 SECTION 302 CFO CERTIFICATION d227415dex312.htm EX-31.2 8042
5 SECTION 906 CEO & CFO CERTIFICATION d227415dex321.htm EX-32.1 4652
6 GRAPHIC g227415g03p02.jpg GRAPHIC 37820
  Complete submission text file 0001193125-11-246843.txt   1103325
Mailing Address 305 CHIPETA WAY SALT LAKE CITY UT 84108
Business Address 305 CHIPETA WAY SALT LAKE CITY UT 84108 801-214-7800
Myrexis, Inc. (Filer) CIK: 0001459450 (see all company filings)

EIN.: 263996918 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-34275 | Film No.: 111088155
SIC: 2834 Pharmaceutical Preparations